Immunohistochemical evidence of lactoferrin in human embryo-fetal bone and cartilage tissues

Cell Biology International

Volumn 34, Issue 8, 2010, Pages 845-849

  Antonio, Ieni ^a   Valeria, Barresi ^a   Maddalena, Grosso ^a   Giovanni, Tuccari ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Chondroblast; Immature osteocyte; Immunohistochemistry; Lactoferrin; Mesenchymal cell

Indexed keywords

FORMALDEHYDE; IRON BINDING PROTEIN; LACTOFERRIN; MONOCLONAL ANTIBODY; PARAFFIN;

ADULT; AGED; ARTICLE; AUTOPSY; BONE DEVELOPMENT; BONE GROWTH; BONE TISSUE; CARTILAGE; CARTILAGE CELL; CELL CULTURE; CONTROLLED STUDY; EMBEDDING; EMBRYO; ENCHONDRAL OSSIFICATION; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MESENCHYME CELL; PERIOSTEUM; PROTEIN EXPRESSION;

ANTIBODIES, MONOCLONAL; BONE AND BONES; CARTILAGE; FEMALE; FETUS; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; LACTOFERRIN; MALE;

ANIMALIA; MURINAE;

EID: 77956099470     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20090358     Document Type: Article

References (32)

1. Barresi G, Tuccari G. Lactoferrin in benign hypertrophy and carcinomas of the prostatic gland. Virchows Arch A Pathol Anat Histopathol 1984;403:59-66.
2. Baveye S, Elass E, Mazurier J, Spik G, Legrand D. Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin Chem Lab Med 1999;37:281-6.
3. Bonewald LF, Johnson ML. Osteocytes, mechanosensing and Wnt signaling. Bone 2008;42:606-15.
4. Brock J. Lactoferrin: a multifunctional immunoregulatory protein? Immunol Today 1995;16:417-9.
5. Cornish J. Lactoferrin promotes bone growth. Biometals 2004;17:331-5
6. Cornish J, Callon KE, Naot D, Palmano KP, Banovic T, Bava U et al. Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology 2004;145:366-74.
7. Cornish J, Palmano K, Callon KE, Watson M, Lin JM, Valenti P et al. Lactoferrin and bone; structure-activity relationships. Biochem Cell Biol 2006;84:297-302.
8. Cornish J and Naot D. Lactoferrin as an effector molecule in the skeleton. Biometals 2010;23:425-430.
9. Elass E, Masson M, Mazurier J, Legrand D. Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycans-binding ability of interleukin-8 in human endothelial cells. Infect Immun 2002;70:1860-6.
10. Giuffré G, Arena F, Scarfì R, Simone A, Todaro P, Tuccari G. Lactoferrin immunoexpression in endometrial carcinomas: relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival. Oncol Rep 2006;16(2):257-63.
11. Giuffré G, Barresi V, Skliros C, Barresi G, Tuccari G. Immunoexpression of lactoferrin in human sporadic renal cell carcinomas. Oncol Rep 2007;17:1021-6.
12. Ieni A, Barresi V, Grosso M, Rosa MA, Tuccari G. Lactoferrin immunoexpression in human normal and neoplastic bone tissue. J Bone Miner Metab 2009a;27:364-71.
13. Ieni A, Barresi V, Grosso M, Rosa MA, Tuccari G. Immunolocalization of lactoferrin in cartilage-forming neoplasms. J Orthop Sci 2009b;14:732-7.
14. Karsenty G. Transcriptional control of skeletogenesis. Annu Rev Genom Hum Genet 2008;9:183-96.
15. Kimber I, Cumberbatch M, Dearman RJ, Headon DR, Bhushan M, Griffiths CE. Lactoferrin: influences on Langerhans cells, epidermal cytokines, and cutaneous inflammation. Biochem Cell Biol 2002;80:103-7.
16. Levay PF, Viljoen M. Lactoferrin: a general review. Haematologica 1995;80:252-67.
17. Lö nnerdal B, Iyer S. Lactoferrin: molecular structure and biological function. Annu Rev Nutr 1995;15:93-110.
18. Mason DY, Taylor CR. Distribution of transferrin, ferritin, and lactoferrin in human tissues. J Clin Pathol 1978;31:316-27.
19. Naot D, Grey A, Reid IR, Cornish J. Lactoferrin - a novel bone growth factor. Clin Med Res 2005;3:93-101.
20. Penco S, Scarfi S, Giovine M, Damonte G, Millo E, Villaggio B et al. Identification of an import signal for, and the nuclear localization of, human lactoferrin. Biotechnol Appl Biochem 2001;34:151-9.
21. Reitamo S, Konttinen YT, Dodd S, Adinolfi M. Distribution of lactoferrin in human fetal tissues. Acta Paediatr Scand 1981;70:395-8.
22. Riggs BL, Melton LJ 3rd. Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density. J Bone Miner Res 2002;17:11-4.
23. Roiron D, Amouric M, Marvaldi J, Figarella C. Lactoferrin-binding sites at the surface of HT29-D4 cells. Comparison with transferrin. Eur J Biochem 1989;186:367-73.
24. Takayama Y, Mizumachi K. Effect of lactoferrin-embedded collagen membrane on osteogenic differentiation of human osteoblast-like cells. J Biosci Bioeng 2009;107:191-5.
25. Tuccari G, Barresi G. Immunohistochemical demonstration of lactoferrin in follicular adenomas and thyroid carcinomas. Virchows Arch A Pathol Anat Histopathol 1985;406:67-74.
26. Tuccari G, Barresi G, Arena F, Inferrera C. Immunocytochemical detection of lactoferrin in human gastric carcinomas and adenomas. Arch Pathol Lab Med 1989;113:912-5.
27. Tuccari G, Rizzo A, Crisafulli C, Barresi G. Iron-binding proteins in human colorectal adenomas and carcinomas: an immunocytochemical investigation. Histol Histopathol 1992;7:543-7.
28. Tuccari G, Rossiello R, Barresi G. Iron binding proteins in gallbladder carcinomas. An immunocytochemical investigation. Histol Histopathol 1997;12:671-6.
29. Tuccari G, Giuffré G, Scarfì R, Simone A, Todaro P, Barresi G. Immunolocalization of lactoferrin in surgically resected pigmented skin lesions. Eur J Histochem 2005;49:33-8.
30. Ward PP, Mendoza-Meneses M, Mulac-Jericevic B, Cunningham GA, Saucedo-Cardenas O, Teng CT et al. Restricted spatiotemporal expression of lactoferrin during murine embryonic development. Endocrinology 1999;140:1852-60.
31. Weinberg ED Human lactoferrin: a novel therapeutic with broad spectrum potential. J Pharm Pharmacol 2001;53:1303-10.
32. Zhou Y, Zeng Z, Zhang W, Xiong W, Wu M, Tan Y et al. Lactotransferrin: a candidate tumor suppressor-deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway. Int J Cancer 2008;123:2065-72.